Evaluation of a novel class of sulfonanilides for targeted treatment of multiple myeloma: Dual-mechanism compounds inhibiting HIF1 alpha-signaling and inducing apoptosis Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Hose, D
  • Seckinger, A
  • Goldschmidt, H
  • Meissner, T
  • Leber, Brian
  • Neben, K
  • Hillengass, J
  • Bertsch, U
  • Janssen, B
  • Klein, B
  • Lewis, J
  • Vanderkerken, K
  • Schultes, C

publication date

  • September 1, 2011